BridgeBio Pharma, Inc. (BBIO)
74.29
+0.02
(+0.03%)
USD |
NASDAQ |
Nov 06, 16:00
74.40
+0.11
(+0.15%)
After-Hours: 20:00
BridgeBio Pharma Free Cash Flow : -369.80M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -369.80M |
| June 30, 2026 | -437.79M |
| March 31, 2026 | -452.02M |
| December 31, 2025 | -455.50M |
| September 30, 2025 | -597.61M |
| June 30, 2025 | -667.47M |
| March 31, 2025 | -509.44M |
| December 31, 2024 | -529.63M |
| September 30, 2024 | -456.32M |
| June 30, 2024 | -419.68M |
| March 31, 2024 | -605.72M |
| December 31, 2023 | -529.03M |
| September 30, 2023 | -496.70M |
| June 30, 2023 | -486.96M |
| March 31, 2023 | -407.54M |
| December 31, 2022 | -425.82M |
| Date | Value |
|---|---|
| September 30, 2022 | -469.32M |
| June 30, 2022 | -496.42M |
| March 31, 2022 | -556.07M |
| December 31, 2021 | -546.18M |
| September 30, 2021 | -508.16M |
| June 30, 2021 | -477.37M |
| March 31, 2021 | -471.56M |
| December 31, 2020 | -407.23M |
| September 30, 2020 | -386.78M |
| June 30, 2020 | -302.42M |
| March 31, 2020 | -284.62M |
| December 31, 2019 | -258.72M |
| September 30, 2019 | -227.93M |
| June 30, 2019 | -218.98M |
| March 31, 2019 | -184.20M |
| December 31, 2018 | -154.82M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Ionis Pharmaceuticals, Inc. | -567.50M |
| Pfizer Inc. | 11.79B |
| Cytokinetics, Inc. | -588.58M |
| Vertex Pharmaceuticals, Inc. | 3.202B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -44.17M |
| Cash from Investing (Quarterly) | 36.61M |
| Cash from Financing (Quarterly) | 863.01M |
| Free Cash Flow Per Share (Quarterly) | -0.2268 |
| Free Cash Flow to Equity (Quarterly) | -56.22M |
| Free Cash Flow to Firm (Quarterly) | 12.23M |
| Free Cash Flow Yield | -2.55% |